Humacyte, Inc.
Last 30 daysInsiders bought $5.62K · 1 buyer, led by Keith Anthony Jones (Director) with $5.62K. No qualifying insider sales.
Showing the first 6 of 13 trades on this page.
Director
Stock Options (right to buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Stock Options (right to buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Stock Options (right to buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Stock Options (right to buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Stock Options (right to buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
President, CEO and Director
Stock Options (right to buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Stock Options (right to buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Stock Options (right to buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Stock Options (right to buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Stock Options (right to buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Stock Options (right to buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Stock Options (right to buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Stock Options (right to buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
| Reporting insider | Security / transaction | Amount / price | Value | Traded / disclosed | Source |
|---|---|---|---|---|---|
| Director | Stock Options (right to buy)Grant or award | Derivative units125,000Award · no purchase price | Non-cash award | Oct 6Filed Oct 7 · 1d later | SEC filing |
| Director | Stock Options (right to buy)Grant or award | Derivative units125,000Award · no purchase price | Non-cash award | Oct 6Filed Oct 7 · 1d later | SEC filing |
| Director | Stock Options (right to buy)Grant or award | Derivative units80,000Award · no purchase price | Non-cash award | Jun 11Filed Jun 12 · 1d later | SEC filing |
| Director | Stock Options (right to buy)Grant or award | Derivative units80,000Award · no purchase price | Non-cash award | Jun 11Filed Jun 12 · 1d later | SEC filing |
| Director | Stock Options (right to buy)Grant or award | Derivative units80,000Award · no purchase price | Non-cash award | Jun 11Filed Jun 12 · 1d later | SEC filing |
| President, CEO and Director | Stock Options (right to buy)Grant or award | Derivative units80,000Award · no purchase price | Non-cash award | Jun 11Filed Jun 12 · 1d later | SEC filing |
| Director | Stock Options (right to buy)Grant or award | Derivative units80,000Award · no purchase price | Non-cash award | Jun 11Filed Jun 12 · 1d later | SEC filing |
| Director | Stock Options (right to buy)Grant or award | Derivative units80,000Award · no purchase price | Non-cash award | Jun 11Filed Jun 12 · 1d later | SEC filing |
| Director | Stock Options (right to buy)Grant or award | Derivative units80,000Award · no purchase price | Non-cash award | Jun 11Filed Jun 12 · 1d later | SEC filing |
| Director | Stock Options (right to buy)Grant or award | Derivative units80,000Award · no purchase price | Non-cash award | Jun 11Filed Jun 12 · 1d later | SEC filing |
| Director | Stock Options (right to buy)Grant or award | Derivative units80,000Award · no purchase price | Non-cash award | Jun 11Filed Jun 12 · 1d later | SEC filing |
| Director | Stock Options (right to buy)Grant or award | Derivative units80,000Award · no purchase price | Non-cash award | Jun 11Filed Jun 12 · 1d later | SEC filing |
| Director | Stock Options (right to buy)Grant or award | Derivative units0Award · no purchase price | Non-cash award | Jun 11Filed Jun 12 · 1d later | SEC filing |
Humacyte, Inc. - Common Stock · Stock
The filing reports a partial sale for a joint account.
Thomas H TubervilleReporting Senate memberHumacyte, Inc. - Common Stock · Stock
The filing reports a full sale for a joint account.
Thomas H TubervilleReporting Senate memberHumacyte Inc · Stock
The filing reports a purchase for a joint account.
Thomas H TubervilleReporting Senate memberHumacyte, Inc. - Common Stock · Stock
The filing reports a purchase for a joint account.
Thomas H TubervilleReporting Senate memberHumacyte, Inc. - Common Stock · Stock
The filing reports a purchase for a joint account.
Thomas H TubervilleReporting Senate member$38,580 of common-equity purchase value after transaction-age decay across 180 days.
3 distinct reporting-owner group(s). Joint rows count once; identity is not proof of discretion.
At least one row increased reported same-security holdings by 10% or established a new reported position; indirect interests may overlap.
This score describes qualifying insider purchases at issuer level. Read the methodology
Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.
Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.
